Cargando…

Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients

INTRODUCTION: Agonistic autoantibodies (Aabs) against the angiotensin II receptor type 1 (AT1R) and the endothelin receptor type A (ETAR) have been identified in patients with systemic sclerosis (SSc). In our present study, we examined the expression of the AT1R and the ETAR in human immune cells an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Günther, Jeannine, Kill, Angela, Becker, Mike Oliver, Heidecke, Harald, Rademacher, Judith, Siegert, Elise, Radić, Mislav, Burmester, Gerd-Rüdiger, Dragun, Duska, Riemekasten, Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060229/ https://www.ncbi.nlm.nih.gov/pubmed/24612997 http://dx.doi.org/10.1186/ar4503

Ejemplares similares

Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
por: Kill, Angela, et al.
Publicado: (2014)

Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation
por: Philippe, Aurélie, et al.
Publicado: (2022)

Autoantibodies Targeting AT(1)- and ET(A)-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription Factor
por: Catar, Rusan, et al.
Publicado: (2021)

Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension
por: Tabeling, Christoph, et al.
Publicado: (2022)

Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
por: Weigold, Florian, et al.
Publicado: (2018)

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington’s disease
por: Lee, De-Hyung, et al.
Publicado: (2014)

IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS
por: Hartwig, Jelka, et al.
Publicado: (2020)

Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies
por: Gold, Annika, et al.
Publicado: (2020)

The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers
por: Kopetschke, Katharina, et al.
Publicado: (2015)

Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism
por: Meyer, Lucie S., et al.
Publicado: (2020)

Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies
por: Civieri, Giovanni, et al.
Publicado: (2022)

Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome
por: Yu, Xichun, et al.
Publicado: (2018)

Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
por: Labandeira, Carmen M., et al.
Publicado: (2022)

Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer
por: Wallukat, Gerd, et al.
Publicado: (2020)

Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients
por: Miedema, Jelle R., et al.
Publicado: (2023)

Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease
por: Dimitrijevic, Ivan, et al.
Publicado: (2009)

DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy
por: Zhang, Min-Yu, et al.
Publicado: (2017)

Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies
por: Philogene, Mary Carmelle, et al.
Publicado: (2017)

Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis
por: Kappes, Lucy, et al.
Publicado: (2020)

Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course
por: Miedema, Jelle, et al.
Publicado: (2021)

The Evaluation of Endothelin-1 and Endothelin Receptor Type A Gene Polymorphisms in Patients with Vitiligo
por: Bingül, İlknur, et al.
Publicado: (2016)

Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation
por: Pearl, Meghan H., et al.
Publicado: (2020)

Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting
por: Speck, David, et al.
Publicado: (2022)

Role of agonistic autoantibodies against type-1 angiotensin II receptor in the pathogenesis of retinopathy in preeclampsia
por: Liu, Fang, et al.
Publicado: (2016)

Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19
por: Rodriguez-Perez, Ana I., et al.
Publicado: (2021)

Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis
por: Höppner, Jakob, et al.
Publicado: (2023)

Determination of the endothelin-1 recognition sites of endothelin receptor type A by the directed-degeneration method
por: Han, Seong-Gu, et al.
Publicado: (2017)

Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells
por: Simon, Michèle, et al.
Publicado: (2021)

Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching
por: Yue, Xiaoyang, et al.
Publicado: (2022)

Association of Angiotensin Receptor Autoantibodies With Cardiovascular Abnormalities in Preeclampsia
por: Minhas, Anum S., et al.
Publicado: (2021)

Role of endothelin receptor type B (EDNRB) in lung adenocarcinoma
por: Wei, Feiran, et al.
Publicado: (2020)

Association of Angiotensin II Type 1 Receptor Agonistic Autoantibodies With Outcomes in Patients With Acute Aortic Dissection
por: Wu, Xiao-wei, et al.
Publicado: (2021)

What Makes Antibodies Against G Protein-Coupled Receptors so Special? A Novel Concept to Understand Chronic Diseases
por: Riemekasten, Gabriela, et al.
Publicado: (2020)

Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor
por: Vythoulkas, Dionysios, et al.
Publicado: (2023)

Decoding Angiotensin Receptors: TOMAHAQ‐Based Detection and Quantification of Angiotensin Type‐1 and Type‐2 Receptors
por: Cosarderelioglu, Caglar, et al.
Publicado: (2023)

Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl(4)-Induced Skeletal Muscle Injury
por: Hwang, Ok-Kyung, et al.
Publicado: (2016)

Angiotensin II Type 1 Receptor Antibodies Are Higher in Lupus Nephritis and Vasculitis than Other Glomerulonephritis Patients
por: Szymczak, Maciej, et al.
Publicado: (2022)

Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension
por: Kala, Petr, et al.
Publicado: (2023)

Plasma endothelin-1 and single nucleotide polymorphisms of endothelin-1 and endothelin type A receptor genes as risk factors for normal tension glaucoma
por: Kosior-Jarecka, Ewa, et al.
Publicado: (2016)

The Endothelin Type A Receptor as a Potential Therapeutic Target in Preeclampsia
por: Bakrania, Bhavisha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iak4ij2b4fm6q931nvv9fjok6f